| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
UNC1215
|
1415800-43-9 |
UNC1215
|
1,1'-[2-(苯基氨基)-1,4-亚苯基]二[1-[4-(1-吡咯烷基)-1-哌啶基]甲酮];UNC 1215;UNC1215;CS-714
|
C32H43N5O2 |
529.71612 | |
|
CGK 733
|
905973-89-9 |
CGK 733
|
CGK-733;CGK 733;ALPHA-苯基-N-[2,2,2-三氯-1-[[[(4-氟-3-硝基苯基)氨基]硫代甲酰]氨基]乙基]-苯乙酰胺;CS-713
|
C23H18Cl3FN4O3S |
555.836423 | |
|
GSK-3787
|
188591-46-0 |
GSK-3787
|
4-氯-N-[2-[[5-(三氟甲基)-2-吡啶基]磺酰基]乙基]-苯甲酰胺;GSK3787;GSK 3787;GSK-3787;CS-710
|
C15H12ClF3N2O3S |
393 | |
|
SC-514
|
354812-17-2 |
SC-514
|
SC-514;GK 01140;IKK-2抑制剂;GK 01140;SC 514;SC514;GK-01140;GK01140;CS-707;4-氨基-[2,3']联噻吩-5-甲酰胺
|
C9H8N2OS2 |
224.30262 | |
|
Bevirimat
|
174022-42-5 |
PA-457
|
贝韦立马>99%;PA-458
|
C36H56O6 |
584.832 | |
|
ONX 0914-PR 957
|
960374-59-8 |
ONX-914
|
PR-957;ONX 0914;ONX0914;PR957;PR 957;ONX 0914;ONX0914;ONX-0914;PR-957
|
C31H40N4O7 |
580.6719 | |
|
PR-047
|
935888-69-0 |
ONX912
|
OPROZOMIB;ONX-0912;ONX0912;ONX 0912;PR-047;PR047;PR 047;LY335979 ONX-0912;OPROZOMIB (ONX 0912);ONX-0912;PR-047;奥泼佐米
|
C25H32N4O7S |
532.60918 | |
|
Pirodavir
|
124436-59-5 |
吡罗达韦
|
吡罗达韦
|
C21H27N3O3 |
369.462 | |
|
RN486
|
1242156-23-5 |
RN 486
|
|
C35H35FN6O3 |
606.689203 | 200-110-4 |
|
2-(4-(2-hydroxyethoxy)-3,5-diMethylphenyl)-5,7-diMethoxyquinazolin-4(3H)-one
|
1044870-39-4 |
RVX-28
|
APABETALONE;2-[3,5-二甲基-4-(2-羟基乙氧基)苯基]-5,7-二甲氧基喹唑啉-4(3H)-酮;CS-686;2-(4-(2-羟基乙氧基)-3,5-二甲基苯基)-5,7-二甲氧基喹唑啉-4(3H)-酮;2-(4-(2-羟基乙氧基)-3,7-二甲氧基-4(3H)-酮;RVX-208(RVX 000222)
|
C20H22N2O5 |
370.39908 | 812-112-4 |
|
KY02111
|
1118807-13-8 |
KY 2111
|
CS-677;N-(6-氯-2-苯并噻唑基)-3,4-二甲氧基苯丙酰胺;N-(6-氯-2-苯并噻唑)-3,4-二甲氧基苯丙酰胺
|
C18H17ClN2O3S |
376.85718 | 808-505-5 |
|
Sancycline
|
808-26-4 |
山环素
|
三环素;BONOMYCIN;NORCYCLINE;6-DEMETHYL-6-DEOXYTETRACYCLINE;CS-677;圣环素杂质;去甲氨四环素;生环素;山环素;米诺环素杂质B
|
C21H22N2O7 |
414.41 | 617-177-0 |
|
MK-3697
|
1224846-01-8 |
MK-3697
|
MK-3697;MK3697;MK 3697.;CS-673;MK-3607;N-[(5,6-DIMETHOXYPYRIDIN-2-YL)METHYL]-2-(5-METHYLPYRIDIN-3-YL)-5-(1,3-THIAZOL-2-YL)PYRIDINE-4-CARBOXAMIDE
|
C23H21N5O3S |
447.50954 | |
|
Preladenant
|
377727-87-2 |
瑞德南特
|
SCH-420814;SCH 420814;SCH420814;CS-672;瑞德南特;SCH-420814(瑞德南特);2-(2-呋喃基)-5-氨基-7-[2-[4-[4-(2-甲氧基乙氧基)苯基]-1-哌嗪基]乙基]-7H-吡唑并[4,3-E][1,2,4]三唑并[1,5-C]嘧啶
|
C25H29N9O3 |
503.55626 | |
|
Varlitinib
|
845272-21-1 |
ARRY334543
|
ARRY-334543;ARRY 334543;ARRY334543;CS-663;VARLITINIB (ARRY-334543;ASLAN001);ARRY-334543;ARRY334543
|
C22H19ClN6O2S |
466.94326 | |
|
LY 344864
|
186544-26-3 |
LY344864
|
(R)-N-[3-(二甲基氨基)-2,3,4,9-四氢-1H-咔唑-6-基]-4-氟苯甲酰胺;LY344864;LY-344864;CS-660
|
C21H22FN3O |
351.423 | |
|
GSK1014802(CNV1014802)
|
934240-30-9 |
GSK11482
|
RAXATRIGINE;CNV1014802;GSK-1014802;GSK-1014802;RAXATRIGINE;CS-657;CNV-1014802;RAXATRIGINE;VIXOTRIGINE;BIIB074
|
C18H19FN2O2 |
314.354063 | |
|
E-3810
|
1058137-23-7 |
Lucitanib
|
德立替尼,E3810;德立替尼;6-[[7-[(1-氨基环丙基)甲氧基]-6-甲氧基-4-喹啉基]氧基]-N-甲基-1-萘甲酰胺
|
C26H25N3O4 |
443.4944 | |
|
LY 2874455
|
1254473-64-7 |
LY2874455
|
4-[(1E)-2-[5-[(1R)-1-(3,5-二氯-4-吡啶基)乙氧基]-1H-吲唑-3-基]乙烯基]-1H-吡唑-1-乙醇;LY 2874455,5-二氯-4-吡啶基)乙氧基]-1H-吲唑-3-基]乙烯基]-1H-吡唑-1-乙醇
|
C21H19Cl2N5O2 |
444.31386 | |
|
BMS-777607
|
1196681-44-3 |
BMS 77767
|
N-[4-(2-AMINO-3-CHLOROPYRIDIN-4-YL)OXY-3-FLUOROPHENYL]-4-ETHOXY-1-(4-FLUOROPHENYL)-2-OXOPYRIDINE-3-C;CS-639
|
C25H19ClF2N4O4 |
512.8925664 |
药智官方微信
药智官方微博
